Ultragenyx Pharmaceutical Stock Price. Everything You Need To Know About The Ultragenyx Pharmaceutical Stock!
Ultragenyx Pharmaceutical, Inc. engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. The company is headquartered in Novato, California and currently employs 1,311 full-time employees. The company went IPO on 2014-01-31. The firm is focused on the identification, acquisition, development, and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. The Company’s therapies and clinical-stage pipeline consist of four product categories, such as biologics, small molecules, gene therapy, and nucleic acid product candidates. The Company’s four approved product candidates include Crysvita (burosumab) is for the treatment of X-linked hypophosphatemia (XLH), and tumor-induced osteomalacia (TIO); Mepsevii (vestronidase alfa) is for the treatment of mucopolysaccharidosis VII (MPSVII) or Sly Syndrome; Dojolvi (triheptanoin) is for the treatment of long-chain fatty acid oxidation disorders or LC-FAOD, and Evkeeza (evinacumab) is for the treatment of homozygous familial hypercholesterolemia (HoFH). The firm’s clinical product candidates include DTX401, DTX301, UX143, GTX-102, UX701 and UX053.
Ultragenyx Pharmaceutical Stock Price. Everything You Need To Know About The Ultragenyx Pharmaceutical Stock! performance
- Employees 1311
- Company HQ Novato
- Website https://www.ultragenyx.com/
- RARE Asset Type Common Stock
- RARE Market Capitalization 3.6B
- Earnings Per Share -8.25
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you a retail investor looking to expand your investment portfolio? Look no further than Ultragenyx Pharmaceutical. As a Content Marketing expert at Zorion, an investment platform catering to individuals from Malaysia, Thailand, Indonesia, and Vietnam, I understand the need for informed investment decisions. Ultragenyx Pharmaceutical, a leader in the biopharmaceutical industry, offers an exciting opportunity for investors from these countries to invest in real US stocks. With our investment insights and recommendations, you can navigate the world of biotech and make educated decisions about your investments. Additionally, access our comprehensive resources and educational materials to further your knowledge in investing in Ultragenyx Pharmaceutical from Malaysia, Thailand, Indonesia, and Vietnam efficiently and confidently.
